Javascript must be enabled to continue!
Amyotrophic lateral sclerosis among chamorro migrants from guam
View through CrossRef
AbstractAmyotrophic lateral sclerosis (ALS), which occurs in unusually high incidence among the Chamorro people on the island of Guam, has developed in 28 Chamorro migrants‐24 of whom had onset in the United States, Japan, Germany, or Korea‐‐after periods of absence from Guam of 1 to 34 years. Thus, the latency period for the disease, if caused by environmental factors on Guam, may be over three decades. Four further patients developed ALS within 1 to 14 years of their return to Guam after long‐term residence in the continental United States. The minimum exposure time to environmental variables on Guam, based on age at migration, was 18 years, and all patients had spent their childhood and adolescence on Guam. Estimates of crude mortality rates for ALS from these data are considerably higher than for the United States population, and lower than the ALS mortality rates for nonmigrant Chamorros on Guam.
Title: Amyotrophic lateral sclerosis among chamorro migrants from guam
Description:
AbstractAmyotrophic lateral sclerosis (ALS), which occurs in unusually high incidence among the Chamorro people on the island of Guam, has developed in 28 Chamorro migrants‐24 of whom had onset in the United States, Japan, Germany, or Korea‐‐after periods of absence from Guam of 1 to 34 years.
Thus, the latency period for the disease, if caused by environmental factors on Guam, may be over three decades.
Four further patients developed ALS within 1 to 14 years of their return to Guam after long‐term residence in the continental United States.
The minimum exposure time to environmental variables on Guam, based on age at migration, was 18 years, and all patients had spent their childhood and adolescence on Guam.
Estimates of crude mortality rates for ALS from these data are considerably higher than for the United States population, and lower than the ALS mortality rates for nonmigrant Chamorros on Guam.
Related Results
Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis
Abstract
Amyotrophic lateral sclerosis is a progressive neurodegenerative syndrome characterized by loss of motor neurons. Cognit...
Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration
Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration
Abstract
TDP-43 is mislocalized from the nucleus and aggregates within the cytoplasm of affected neurons in cases of amyotrophic lateral sclerosis. TDP-43 pathology ...
Amyotrophic lateral sclerosis: Neural repair strategies based on multi-target synchronous interventions
Amyotrophic lateral sclerosis: Neural repair strategies based on multi-target synchronous interventions
Abstract
Amyotrophic lateral sclerosis is a progressive and fatal neurodegenerative disease that targets motor neurons in the cerebral cortex, medulla oblongata, ...
An open-label Phase 2a study to assess the safety and tolerability of trimetazidine in patients with amyotrophic lateral sclerosis
An open-label Phase 2a study to assess the safety and tolerability of trimetazidine in patients with amyotrophic lateral sclerosis
Abstract
Metabolic imbalance is associated with amyotrophic lateral sclerosis progression. Impaired glucose oxidation and increased reliance on fatty acid oxidation ...
Genetic aspects of amyotrophic lateral sclerosis
Genetic aspects of amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis is a progressive, incurable neurodegenerative disease characterized by motor neuron loss and the development of paralysis and skeletal muscle atrophy....
Amyotrophic lateral sclerosis and parkinsonism‐dementia among Filipino migrants to Guam
Amyotrophic lateral sclerosis and parkinsonism‐dementia among Filipino migrants to Guam
AbstractAmyotrophic lateral sclerosis (ALS) has occurred in 9 Filipino migrants to Guam 1 to 29 years after their arrival and parkinsonism‐dementia (PD) in 2 migrants 13 and 26 yea...
Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations
Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations
Abstract
Amyotrophic lateral sclerosis is a relentless neurodegenerative disease that is mostly fatal within 3–5 years and is diagnosed on evidence of progressive up...
Amyotrophic Lateral Sclerosis and its Masks, a Comorbid Pathology with a Rapid Fatal Outcome: Case Report
Amyotrophic Lateral Sclerosis and its Masks, a Comorbid Pathology with a Rapid Fatal Outcome: Case Report
INTRODUCTION. Despite the fact that more than 150 years have passed since the first mention of amyotrophic lateral sclerosis (ALS), the issues of etiology, pathogenesis, diagnosis ...

